创伤后凝血病的血蛋白质体特征:与生物力学和患者结果的联系
Andrew R Gosselin1, Olivia Parker1, Hajer Ali Sinan1
1Department of Biomedical Engineering, Rutgers University, Piscataway, NJ 599 Taylor Road, Room 209, Piscataway, NJ, USA 08854.
Shock (Augusta, Ga.)
|March 2, 2026
概括
创伤患者表现出与血栓形成和稳定性相关的明显的血蛋白质. 识别这些标志物可能会改善凝血病的治疗,并减少受伤后的死亡率.
科学领域:
- 蛋白质组学是指蛋白质组学.
- 创伤研究研究创伤研究
- 凝血科学是一门凝血科学.
背景情况:
- 创伤伤害是导致死亡的主要原因,通常是由于出血和凝固问题.
- 对创伤引起的凝血病的生物途径和治疗点的理解有限.
- 对创伤患者血的蛋白质组分析可以揭示对凝块形成和稳定的洞察力.
研究的目的:
- 为了进行创伤患者血的蛋白质组分析.
- 评估血蛋白和血栓形成/稳定性之间的关系.
- 确定创伤相关凝血病的潜在生物标志物和治疗点.
主要方法:
- 在急诊室到达时从创伤患者收集的血.
- 凝血评估使用风湿学,度和共聚焦显微镜.
- 蛋白质组通过液态染色体质谱测量,并与临床数据和结果相关联.
主要成果:
- 血静过程在健康的捐赠者和创伤患者中更为普遍,严重受伤,存活,没有创伤性脑损伤 (TBI),没有休克.
- 血原激活剂抑制剂-3 (PAI-3) 在幸存者中较高,与更快的凝血和减少的D-二次体相关.
- 与免疫活性相关的PTGDS等蛋白质在未幸存者中较高,与较弱的血栓和增加的D-二次数相关.
结论:
- 探索性蛋白质组分析在创伤患者中确定了潜在的血标记物.
- 这些标志物与凝血和免疫活动有关,可能导致死亡率.
- 鉴定出来的蛋白质可以作为治疗点来治疗受伤后的凝血病.
相关概念视频
Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...


